MedTrace Logo

Possible Pharmacological Effect of Quercetin in the Management of Hyperuricemia - Results From Real-life Clinical Studies

NCT06652035 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 161

Last updated 2024-10-29

No results posted yet for this study

Summary

Quercetin, a natural flavonoid found in various fruits and vegetables, has gained attention for its potential role in managing hyperuricemia. Emerging evidence suggests that quercetin may reduce plasma uric acid levels by inhibiting xanthine oxidase, an enzyme responsible for uric acid production. Additionally, its anti-inflammatory and antioxidant properties could help mitigate the oxidative stress and inflammation associated with hyperuricemia. As a result, quercetin supplementation offers a promising avenue for therapeutic intervention in conditions like gout and other uric acid-related disorders.

Conditions

  • Hyperuricemia

Interventions

DIETARY_SUPPLEMENT

Quevir® (Quercetin Phytosome®)

500 mg Quevir® (Quercetin Phytosome®) tablet

DIETARY_SUPPLEMENT

Bactoblis®

Probiotic Streptococcus Salivarius K12 (ATCC BAA-1024)

Sponsors & Collaborators

  • The University of Urbino Carlo Bo, Italy

    collaborator UNKNOWN

  • Liaquat University of Medical & Health Sciences

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2022-12-31
Completion
2023-06-15

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06652035 on ClinicalTrials.gov